FibroGen Inc (FGEN) Q1 2021 Earnings Call Transcript

·38 min read
FibroGen Inc (FGEN) Q1 2021 Earnings Call Transcript

Thank you, Erica, and good afternoon, everyone and welcome to FibroGen's conference call for fiscal 2021 first quarter. Joining me on today's call are Enrique Conterno, Chief Executive Officer; Dr. Percy Carter, our Chief Scientific Officer; Pat Cotroneo, our Chief Financial Officer; Dr. Mark Eisner, our Chief Medical Officer; Thane Wettig, our Chief Commercial Officer; Chris Chung, our Senior Vice President of China Operations; and Dr. Elias Kouchakji, our Senior Vice President of Clinical Development, Drug Safety and Pharmacovigilance.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting